Increased Prostaglandin Activity [PE] - N0000009526

Name: Table of NDC products with increased prostaglandin activity
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000009526
Pharmacologic Name	Increased Prostaglandin Activity
Pharmacologic Uses	prostaglandin analog
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Increased Prostaglandin Activity

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Increased Prostaglandin Activity [PE].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0781-6184	Tafluprost	Non-Proprietary Name: Tafluprost	Solution/ Drops	Ophthalmic	Sandoz Inc	ACTIVE
17478-609	Zioptan	Non-Proprietary Name: Tafluprost	Solution/ Drops	Ophthalmic	Akorn	ACTIVE
42571-264	Tafluprost	Non-Proprietary Name: Tafluprost Opthalmic	Solution/ Drops	Ophthalmic	Micro Labs Limited	ACTIVE
65302-062	Tafluprost	Non-Proprietary Name: Tafluprost	Solution	Ophthalmic	The Ritedose Corporation	ACTIVE
66993-429	Tafluprost Ophthalmic	Non-Proprietary Name: Tafluprost	Solution/ Drops	Ophthalmic	Prasco Laboratories	ACTIVE
82584-609	Zioptan	Non-Proprietary Name: Tafluprost	Solution/ Drops	Ophthalmic	Thea Pharma Inc.	ACTIVE